Literature DB >> 2938735

Effects of inflammation products on immune systems. Lysophosphatidylcholine stimulates macrophages.

B Z Ngwenya, N Yamamoto.   

Abstract

Microbial infection causes inflammation which stimulates macrophage functions. One of the inflammatory products, lysophosphatidylcholine (lyso-Pc), can stimulate macrophage activities. Treatment of mice with lyso-Pc enhanced spreading and ingestion activities of peritoneal macrophages. In vitro treatment of macrophages with lyso-Pc greatly enhanced spreading but not ingestion activities. However, incubation of a mixture of adherent and nonadherent cells with lyso-Pc produced a markedly enhanced ingestion activity of macrophages, implying the contribution of nonadherent cells to the stimulation of macrophages. Time course studies of the stimulation of these macrophages showed that spreading activity is stimulated immediately, even 30 min, after their contact with lyso-Pc while induction of ingestion activity requires a latent period of about 5 h. When the specificity of the macrophage receptors for ingestion was analyzed using defined immunoglobulins (i.e., IgG and IgM) with or without complement, lyso-Pc-activated macrophages efficiently ingested IgG-coated sheep erythrocytes independent of complement. However, macrophages of the same lyso-Pc-treated mice did not ingest erythrocytes coated with IgM and complement. These observations suggest that lyso-Pc-stimulated macrophages ingest the targets via Fc-receptors but not C3b receptors.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2938735     DOI: 10.1007/bf00199358

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  27 in total

1.  The biocleavage of alkyl glyceryl ethers in Morris hepatomas and other transplantable neoplasms.

Authors:  J F Soodsma; C Piantadosi; F Snyder
Journal:  Cancer Res       Date:  1970-02       Impact factor: 12.701

2.  The action of purified phospholipase B in inflammation and immunity.

Authors:  M Modolell; P G Munder
Journal:  Int Arch Allergy Appl Immunol       Date:  1972

3.  Induction of C3b-mediated phagocytosis in macrophages by distinct populations of lipopolysaccharide-stimulated lymphocytes.

Authors:  D M Wrigley; P H Saluk
Journal:  Infect Immun       Date:  1981-12       Impact factor: 3.441

4.  Development of functional complement receptors during in vitro maturation of human monocytes into macrophages.

Authors:  S L Newman; R A Musson; P M Henson
Journal:  J Immunol       Date:  1980-11       Impact factor: 5.422

5.  Accelerated phospholipid degradation and associated membrane dysfunction in irreversible, ischemic liver cell injury.

Authors:  K R Chien; J Abrams; A Serroni; J T Martin; J L Farber
Journal:  J Biol Chem       Date:  1978-07-10       Impact factor: 5.157

6.  Regional immunotherapy of lung cancer with intrapleural B.C.G.

Authors:  M F McKneally; C Maver; H W Kausel
Journal:  Lancet       Date:  1976-02-21       Impact factor: 79.321

7.  Destruction of human solid tumors by alkyl lysophospholipids.

Authors:  M H Runge; R Andreesen; A Pfleiderer; P G Munder
Journal:  J Natl Cancer Inst       Date:  1980-06       Impact factor: 13.506

8.  Macrophage stimulation by bacterial lipopolysaccharides. I. Cytolytic effect on tumor target cells.

Authors:  W F Doe; P M Henson
Journal:  J Exp Med       Date:  1978-08-01       Impact factor: 14.307

9.  Studies of the macrophage complement receptor. Alteration of receptor function upon macrophage activation.

Authors:  C Bianco; F M Griffin; S C Silverstein
Journal:  J Exp Med       Date:  1975-06-01       Impact factor: 14.307

10.  THE DIFFERENTIATION OF MONONUCLEAR PHAGOCYTES. MORPHOLOGY, CYTOCHEMISTRY, AND BIOCHEMISTRY.

Authors:  Z A COHN; B BENSON
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  12 in total

1.  Clinical significance of enzymatic lysophosphatidylcholine (LPC) assay data in patients with sepsis.

Authors:  W H Cho; T Park; Y Y Park; J W Huh; C-M Lim; Y Koh; D-K Song; S-B Hong
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-12-14       Impact factor: 3.267

2.  Inhibitory effect of 1-O (2 methoxy) hexadecyl glycerol and phenylbutyrate on the malignant properties of human prostate cancer cells.

Authors:  S Reynolds; H Cederberg; S Chakrabarty
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

3.  Activation of macrophages by ether analogues of lysophospholipids.

Authors:  N Yamamoto; B Z Ngwenya; T W Sery; R A Pieringer
Journal:  Cancer Immunol Immunother       Date:  1987       Impact factor: 6.968

4.  Activation process of macrophages after in vitro treatment of mouse lymphocytes with dodecylglycerol.

Authors:  S Homma; N Yamamoto
Journal:  Clin Exp Immunol       Date:  1990-02       Impact factor: 4.330

5.  Inhibitory effect of vitamin D-binding protein-derived macrophage activating factor on DMBA-induced hamster cheek pouch carcinogenesis and its derived carcinoma cell line.

Authors:  Yukiyo Toyohara; Susumu Hashitani; Hiromitsu Kishimoto; Kazuma Noguchi; Nobuto Yamamoto; Masahiro Urade
Journal:  Oncol Lett       Date:  2011-05-13       Impact factor: 2.967

6.  Contribution of N-acetyl-beta-D-galactosamine-specific lectin to Fc receptor-mediated phagocytosis by mouse peritoneal macrophages.

Authors:  Y Aramaki; M Murai; S Tsuchiya
Journal:  Immunology       Date:  1993-07       Impact factor: 7.397

7.  Participation of serum proteins in the inflammation-primed activation of macrophages.

Authors:  N Yamamoto; N P Willett; D D Lindsay
Journal:  Inflammation       Date:  1994-06       Impact factor: 4.092

8.  In vivo and in vitro activation of macrophages with a cyanine photosensitizing dye, platonin.

Authors:  Y Nakagawa; S Homma; I Yamamoto; M Banno; H Nakazato; H Imanaga; N Yamamoto
Journal:  Cancer Immunol Immunother       Date:  1993-08       Impact factor: 6.968

9.  Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.

Authors:  Nobuto Yamamoto; Hirofumi Suyama; Nobuyuki Yamamoto
Journal:  Transl Oncol       Date:  2008-07       Impact factor: 4.243

10.  Induction of immune cell infiltration into murine SCCVII tumour by photofrin-based photodynamic therapy.

Authors:  G Krosl; M Korbelik; G J Dougherty
Journal:  Br J Cancer       Date:  1995-03       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.